Cabot Co. to Post FY2025 Earnings of $5.85 Per Share, Zacks Research Forecasts (NYSE:CBT)

Cabot Co. (NYSE:CBTGet Rating) – Investment analysts at Zacks Research issued their FY2025 earnings per share (EPS) estimates for shares of Cabot in a research report issued to clients and investors on Monday, November 21st. Zacks Research analyst A. Barman expects that the specialty chemicals company will earn $5.85 per share for the year. The consensus estimate for Cabot’s current full-year earnings is $6.53 per share.

Several other research firms also recently weighed in on CBT. Deutsche Bank Aktiengesellschaft upgraded Cabot from a “hold” rating to a “buy” rating and upped their price target for the stock from $80.00 to $90.00 in a research note on Wednesday, November 16th. StockNews.com assumed coverage on Cabot in a research note on Wednesday, October 12th. They issued a “buy” rating on the stock. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Cabot currently has a consensus rating of “Buy” and an average target price of $83.25.

Cabot Stock Up 0.7 %

CBT stock opened at $73.80 on Thursday. Cabot has a fifty-two week low of $50.96 and a fifty-two week high of $78.62. The business’s 50 day moving average price is $69.05 and its two-hundred day moving average price is $69.82. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.05 and a current ratio of 1.65. The company has a market capitalization of $4.15 billion, a price-to-earnings ratio of 20.50 and a beta of 1.39.

Hedge Funds Weigh In On Cabot

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CBT. Meeder Asset Management Inc. bought a new position in shares of Cabot during the 1st quarter valued at $28,000. Bessemer Group Inc. lifted its holdings in shares of Cabot by 1,005.1% during the 3rd quarter. Bessemer Group Inc. now owns 431 shares of the specialty chemicals company’s stock valued at $28,000 after buying an additional 392 shares during the period. Parkside Financial Bank & Trust lifted its holdings in shares of Cabot by 176.0% during the 1st quarter. Parkside Financial Bank & Trust now owns 414 shares of the specialty chemicals company’s stock valued at $28,000 after buying an additional 264 shares during the period. Pinebridge Investments L.P. lifted its holdings in shares of Cabot by 139.0% during the 2nd quarter. Pinebridge Investments L.P. now owns 478 shares of the specialty chemicals company’s stock valued at $30,000 after buying an additional 278 shares during the period. Finally, CWM LLC lifted its holdings in shares of Cabot by 81.0% during the 3rd quarter. CWM LLC now owns 505 shares of the specialty chemicals company’s stock valued at $32,000 after buying an additional 226 shares during the period. 96.48% of the stock is owned by institutional investors.

Cabot Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 9th. Investors of record on Friday, November 25th will be given a $0.37 dividend. The ex-dividend date of this dividend is Wednesday, November 23rd. This represents a $1.48 annualized dividend and a yield of 2.01%. Cabot’s dividend payout ratio (DPR) is presently 41.11%.

About Cabot

(Get Rating)

Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites.

Read More

Earnings History and Estimates for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.